Scott Gottlieb

Former FDA chief: Omicron is definitely here, but don’t rearrange your life

By Tom Howell Jr. - The Washington Times

Former FDA chief Dr. Scott Gottlieb: U.S. finally ahead of Europe in pandemic recovery

By Tom Howell Jr. - The Washington Times

Former FDA chief Gottlieb: UK variant ‘could be here’

By Tom Howell Jr. - The Washington Times

Operation Warp Speed: We won’t fiddle with Pfizer dosing plan

By Tom Howell Jr. - The Washington Times

Scott Gottlieb says Trump failed by health officials with faulty information

By Valerie Richardson - The Washington Times

Scott Gottlieb and AEI scholar agree: Officials have to stop politicizing mask-wearing

By David Sherfinski - The Washington Times

Scott Gottlieb, former FDA chief: U.S. must improve coronavirus testing for asymptomatic patients

By David Sherfinski - The Washington Times

Dr. Scott Gottlieb: Coronavirus cases, hospitalizations will increase in May as states open up

By David Sherfinski - The Washington Times

Scott Gottlieb, former FDA chief: Could be late 2021 before coronavirus vaccine available ‘at scale’

By David Sherfinski - The Washington Times

Scott Gottlieb: Wouldn’t be surprised if Brian Kemp revises reopening plan in Georgia

By David Sherfinski - The Washington Times

Scott Gottlieb, former FDA head: ‘Hopefully,’ we’ll be there on testing by September

By David Sherfinski - The Washington Times

Scott Gottlieb, former Trump FDA chief, joins Larry Hogan’s coronavirus team

By Adam Zielonka - The Washington Times

Scott Gottlieb, FDA chief: We must chase coronavirus therapy as urgently as vaccine

By Tom Howell Jr. - The Washington Times

EDITORIAL: Scott Gottlieb’s resignation gives the FDA another opportunity to do the right thing

By THE WASHINGTON TIMES

US health officials move to tighten sales of e-cigarettes

By MATTHEW PERRONE - Associated Press

New FDA vaping regulation makes no sense

By Matt Mackowiak

HHS chief says director of National Cancer Institute will lead FDA for now

By Tom Howell Jr. - The Washington Times

What ought to happen next at FDA

By Carrie Wade and David Bahr

FDA chief Scott Gottlieb steps down after nearly 2 years

By MATTHEW PERRONE - Associated Press

Scott Gottlieb, FDA commissioner, resigns

By Tom Howell Jr. - The Washington Times

Get today’s top stories in under five minutes Listen to the Front Page Podcast

WATCH: Powerus unveils Guardian 3 drone interceptor at AUSA 2026 Guy Taylor has more

WATCH: Will gas, grocery and heating oil prices cost Republicans control of Congress?

Latest Stories

Former FDA chief: Omicron is definitely here, but don’t rearrange your life

Former FDA chief Dr. Scott Gottlieb: U.S. finally ahead of Europe in pandemic recovery

Former FDA chief Gottlieb: UK variant ‘could be here’

Operation Warp Speed: We won’t fiddle with Pfizer dosing plan

Scott Gottlieb says Trump failed by health officials with faulty information

Scott Gottlieb and AEI scholar agree: Officials have to stop politicizing mask-wearing

Scott Gottlieb, former FDA chief: U.S. must improve coronavirus testing for asymptomatic patients

Dr. Scott Gottlieb: Coronavirus cases, hospitalizations will increase in May as states open up

Scott Gottlieb, former FDA chief: Could be late 2021 before coronavirus vaccine available ‘at scale’

Scott Gottlieb: Wouldn’t be surprised if Brian Kemp revises reopening plan in Georgia

Scott Gottlieb, former FDA head: ‘Hopefully,’ we’ll be there on testing by September

Scott Gottlieb, former Trump FDA chief, joins Larry Hogan’s coronavirus team

Scott Gottlieb, FDA chief: We must chase coronavirus therapy as urgently as vaccine

EDITORIAL: Scott Gottlieb’s resignation gives the FDA another opportunity to do the right thing

US health officials move to tighten sales of e-cigarettes

New FDA vaping regulation makes no sense

HHS chief says director of National Cancer Institute will lead FDA for now

What ought to happen next at FDA

FDA chief Scott Gottlieb steps down after nearly 2 years

Scott Gottlieb, FDA commissioner, resigns